Extensive psoriasis treatment, Efficacy of Acitretin in Severe Psoriasis
Psoriasis Treatment – The Best 3 Remedies for Psoriasis – salesfunnel.hu
Jogosultság Kritériumok: Inclusion Criteria: Subjects must present with a clinical diagnosis of stable at least 3 months plaque-type psoriasis. Subjects must have an IGA grade of 3 moderate at the Baseline Visit Exclusion Criteria: Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative or pustular psoriasis Other inflammatory skin disease that may confound the evaluation of the plaque psoriasis e.
Presence of pigmentation, extensive scarring, or pigmented lesions or sunburn which could interfere with the rating of efficacy parameters. History of psoriasis unresponsive to topical treatments.
- Ma arthritis psoriaticában is a methotrexat az első választás, ebben a betegségben még a leflunomid LEFciklosporin CsA és szulfaszalazin SSZ is alkalmazható.
- Vörös foltok és a bőr hámlása
History of organ transplant requiring immunosuppression, HIV, or other immunocompromised state. Use within days prior to Baseline Visit of biologic treatment for psoriasis e.
This study highlights data from two existing clinical trials to capture PASI 50 and PASI 75 responder rates which represent a common metric used in current psoriasis clinical trials. A review of pharmacokinetics, safety and a discussion of relapse rate establish acitretin as an efficacious, convenient, oral treatment for initial and maintenance therapy of severe psoriasis.
Have received treatment for any type of cancer within 5 years of the Baseline Extensive psoriasis treatment except skin cancer and cervical cancer in situ are allowed within 1 year of the Baseline Visit. Use within 60 days prior to the Baseline Visit of: 1 immunosuppressive drugs e.
Use within 30 days prior to the Baseline Visit of: 1 systemic steroids, 2 PUVA therapy, 3 systemic anti-inflammatory agents e. Inhaled, intraocular, and intranasal steroids are allowed. Use within 14 days prior to the Baseline Visit of: 1 topical antipsoriatic drugs e.